These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8901004)

  • 21. Differential attenuation of some effects of haloperidol in rats given scopolamine.
    Setler P; Sarau H; McKenzie G
    Eur J Pharmacol; 1976 Sep; 39(1):117-26. PubMed ID: 986946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effects of risperidone on catalepsy and cerebral dopamine, serotonin and GABA metabolism in the rat: comparison with haloperidol].
    Kikumoto O; Okamoto Y; Hayakawa H; Yokota N; Kawai K; Motohashi N; Yamawaki S
    Yakubutsu Seishin Kodo; 1993 Feb; 13(1):39-42. PubMed ID: 7686319
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition by apomorphine of the metoclopramide-induced catalepsy and increase in striatal homovanillic acid content.
    Ahtee L
    Br J Pharmacol; 1975 Nov; 55(3):381-5. PubMed ID: 1239323
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute versus chronic haloperidol: relationship between tolerance to catalepsy and striatal and accumbens dopamine, GABA and acetylcholine release.
    Osborne PG; O'Connor WT; Beck O; Ungerstedt U
    Brain Res; 1994 Jan; 634(1):20-30. PubMed ID: 7908848
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative studies of sulpiride and classical neuroleptics on induction of catalepsy, locomotor activity, and brain dopamine metabolism in mice.
    Fujiwara H
    Pharmacol Biochem Behav; 1992 Feb; 41(2):301-8. PubMed ID: 1349435
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Taurine prevents haloperidol-induced changes in striatal neurochemistry and behavior.
    Lidsky TI; Schneider JS; Yablonsky-Alter E; Zuck LG; Banerjee SP
    Brain Res; 1995 Jul; 686(1):104-6. PubMed ID: 7583261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cannabidiol attenuates haloperidol-induced catalepsy and c-Fos protein expression in the dorsolateral striatum via 5-HT1A receptors in mice.
    Sonego AB; Gomes FV; Del Bel EA; Guimaraes FS
    Behav Brain Res; 2016 Aug; 309():22-8. PubMed ID: 27131780
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Haloperidol-induced catalepsy is mediated by postsynaptic dopamine receptors.
    Sanberg PR
    Nature; 1980 Apr; 284(5755):472-3. PubMed ID: 7189016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quinolinic acid lesions of rat striatum abolish D1- and D2-dopamine receptor-mediated catalepsy.
    Calderon SF; Sanberg PR; Norman AB
    Brain Res; 1988 May; 450(1-2):403-7. PubMed ID: 2969764
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of fentanyl and droperidol on the dopamine metabolism of the rat striatum.
    Freye E; Kuschinsky K
    Pharmacology; 1976; 14(1):1-7. PubMed ID: 986654
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glutamatergic neurotransmission in the inferior colliculus influences intrastriatal haloperidol-induced catalepsy.
    Medeiros P; Viana MB; Barbosa-Silva RC; Tonelli LC; Melo-Thomas L
    Behav Brain Res; 2014 Jul; 268():8-13. PubMed ID: 24667361
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Striatal N-methyl-D-aspartate receptors in haloperidol-induced catalepsy.
    Yoshida Y; Ono T; Kizu A; Fukushima R; Miyagishi T
    Eur J Pharmacol; 1991 Oct; 203(2):173-80. PubMed ID: 1686859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alterations in striatal neuropeptide Y system activity of rats with haloperidol-induced behavioral supersensitivity.
    Obuchowicz E; Krysiak R; Wieronska JM; Smialowska M; Herman ZS
    Neuropeptides; 2005 Oct; 39(5):515-23. PubMed ID: 16154634
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dopamine receptor blocking action of a dibenzothiepin derivative isofloxythepin in rats.
    Yamada K; Matsuo N; Nagashima M; Kumagai M; Furukawa T
    Clin Exp Pharmacol Physiol; 1989 Feb; 16(2):109-16. PubMed ID: 2565774
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The alpha 2-adrenoceptor antagonist idazoxan reverses catalepsy induced by haloperidol in rats independent of striatal dopamine release: role of serotonergic mechanisms.
    Invernizzi RW; Garavaglia C; Samanin R
    Neuropsychopharmacology; 2003 May; 28(5):872-9. PubMed ID: 12644843
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduced expression of haloperidol conditioned catalepsy in rats by the dopamine D3 receptor antagonists nafadotride and NGB 2904.
    Banasikowski TJ; Beninger RJ
    Eur Neuropsychopharmacol; 2012 Oct; 22(10):761-8. PubMed ID: 22410316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of piracetam on the central dopaminergic transmission.
    Rägo LK; Allikmets LH; Zarkovsky AM
    Naunyn Schmiedebergs Arch Pharmacol; 1981 Dec; 318(1):36-7. PubMed ID: 6276786
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiation-induced increases in sensitivity of cataleptic behavior to haloperidol: possible involvement of prostaglandins.
    Joseph JA; Kandasamy SB; Hunt WA; Dalton TK; Stevens S
    Pharmacol Biochem Behav; 1988 Feb; 29(2):335-41. PubMed ID: 3362928
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SCH 23390 may alter dopamine-mediated motor behaviour via striatal D-1 receptors.
    Boyce S; Kelly E; Davis A; Fleminger S; Jenner P; Marsden CD
    Biochem Pharmacol; 1985 May; 34(10):1665-9. PubMed ID: 2988552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amphetamine-haloperidol interactions in rat striatum: failure to correlate behavioral effects with dopaminergic and cholinergic dynamics.
    Kuczenski R; Schmidt D; Leith N
    Brain Res; 1977 Apr; 126(1):117-29. PubMed ID: 558038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.